科拓生物(300858) - 2024年度财务决算报告

（一）资产情况分析 | | | | | | 单位：元 | | --- | --- | --- | --- | --- | --- | | 项目 | 2024 | 年 月 日 12 31 | 年 月 日 2024 1 | 1 | 增减幅度 | | 货币资金 | | 108,635,367.47 | 191,596,438.14 | | -43.30% | | 交易性金融资产 | | 296,731,399.24 | 152,262,249.57 | | 94.88% | | 应收票据 | | - | 2,273,418.18 | | -100.00% | | 应收账款 | | 56,473,758.30 | 65,395,480.10 | | -13.64% | | 预付款项 | | 9,812,714.38 | 5,716,142.79 | | 71.67% | | 其他应收款 | | 1,165,043.72 | 887,673.85 | | 31.25% | | 存货 | | 46,599,458.64 | 39,222,641.95 | | 18.81% | | 一年内到期的非流动资产 | | 425, ...